Middle East and Africa Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Ph

Middle East and Africa Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) 

The lymphedema treatment market in MEA is expected to grow from US$ 195.67 million in 2021 to US$ 237.30 million by 2028; it is estimated to grow at a CAGR of 2.8% from 2021 to 2028. According to one report, treatment of lymphedema is primarily driven by symptom management, volume reduction, and infection prevention. For instance, the first stage of treatment for lymphedema is conservative management. Complete decongestive therapy (CGT) has become the forefront of physiotherapeutic conservative management. Additionally, surgical treatment approaches provide good adherence to conservative management. Moreover, the new minimally invasive vascularized lymph node transfer for lymphedema has gained significant attention. Benefits associated with lymph node transfer involve a significant reduction of pain and swelling in the lymphedema anatomy. Also, the surgery allows patients to decrease their antibiotic use, adding quality-of-life benefits among the patient pool. Further, patients diagnosed with breast, skin penile, bladder, and gynecological cancers may undergo lymph nodes procedure. Lymphedema is a chronic, incurable disease affecting a patient's physical and mental well-being. Term-based care proves to be a multidisciplinary approach for patient management. The term-based care team includes people from physical rehabilitation, vascular medicine, plastic surgery, radiology, oncology, infectious disease, and social work. The team can provide a thorough evaluation to assess the etiology of limb swelling, optimize conservative care, and offer surgical treatment for appropriate candidates. Furthermore, innovative treatment options such as rehabilitation programs prove beneficial for lymphedema treatment. One report states that outpatient rehabilitation offers programs and different services for individuals for proper management and lucrative benefits for patients suffering from lymphedema swelling or an abnormal accumulation of fluid beneath the skin due to a problem with the lymphatic system. Such innovative treatment options significantly reduce the rising prevalence of lymphedema by giving promising results, thereby driving the market growth.

Based on treatment type, the compression devices and bandaging segment led the MEA lymphedema treatment market in 2020. The compression treatment reduces swelling caused by a buildup of lymph fluid (lymphedema). The pressure exerted by such compression devices helps the trapped lymph fluid to flow through the lymph vessels. Additionally, such devices also act as an extra force for the muscles to work satisfactory in favor of lymphedema patients. Apart from that, bandaging for lymphedema is called multi-layered lymphedema bandaging (MLLB). The main aim is to help lymph fluid to drain and stop building up and also assist parts of the body to get back to their normal shape. Such aforementioned factors impact positively for the overall segmental growth ultimately contributing for the growth of lymphedema treatment market.

The COVID-19 pandemichad shown substantial effects in the Middle East and Africa. On August 4 2021, several COVID-19 cases had been reported, inIran (3,979,727), South Africa (2,236,805), Israel (882,798), UAE (685,462), and Saudi Arabia (528,952) During the COVID-19 pandemic mass, drug administration interventions neglected tropical diseases, including lymphatic filariasis have been halted. In view of current pandemic situation WHO issued the recommendation on 1st April 2020 t put all the community surveys, active cases finding activities and mass treatment campaigns on hold.

The overall MEA lymphedema treatment market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast of the MEA lymphedema treatment market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights into the topic. The participants typically involved in this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the MEA lymphedema treatment market. 3M Company, BSN medical GmbH, Huntleigh Healthcare Limited, Lohmann & Rauscher GmbH & Co. KG, Mego Afek ltd, Sigvaris Group, and Smith & Nephew are a few key players operating in the market in this region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA lymphedema treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA lymphedema treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the lymphedema treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution